Colloids for nanobiotechnology : synthesis, characterization and potential applications /

Detalles Bibliográficos
Clasificación:Libro Electrónico
Otros Autores: Parak, Wolfgang J. (Editor ), Feliu, Neus (Editor )
Formato: Electrónico eBook
Idioma:Inglés
Publicado: Amsterdam. Netherlands : Elsevier, 2020.
Colección:Frontiers of nanoscience ; v. 16.
Temas:
Colloids.
Nanobiotechnology.
Nanobiotechnologie.
Colloids
Nanobiotechnology
Acceso en línea:Texto completo
Tabla de Contenidos:
  • Intro
  • Colloids for Nanobiotechnology: Synthesis, Characterization and Potential Applications
  • Copyright
  • Contents
  • Contributors
  • Chapter 1: Colloids for nanobiotechnology: An introduction
  • Chapter 2: Surface-enhanced Raman scattering (SERS) sensing of nucleic acids
  • 2.1. Introduction
  • 2.2. Indirect SERS detection of nucleic acids
  • 2.3. Direct SERS detection of nucleic acids
  • 2.4. Conclusions
  • Acknowledgments
  • References
  • Chapter 3: Energy transfer with nanoparticles for in vitro diagnostics
  • 3.1. Introduction
  • 3.2. Semiconductor QDs
  • 3.2.1. QDs as FRET donors for IVD
  • 3.2.1.1. Enzyme sensing
  • 3.2.1.2. Nucleic acid sensing
  • 3.2.1.3. Immunoassays
  • 3.2.2. QDs as FRET acceptors for IVD
  • 3.2.2.1. Luminescence lanthanide complex as FRET donor
  • 3.2.2.1.1. Nucleic acid sensing
  • 3.2.2.1.2. Antibody/antigen sensing
  • 3.2.2.2. UCNPs as FRET donors
  • 3.2.3. QDs as FRET donors and acceptors
  • 3.2.3.1. Small molecule sensing
  • 3.2.3.2. Antibody/antigen sensing
  • 3.3. Upconversion nanoparticles
  • 3.3.1. FRET for biosensing with UCNPs
  • 3.3.2. UCNPs as energy donors for IVD
  • 3.3.2.1. Small molecule sensing
  • 3.3.2.2. Nucleic acid sensing
  • 3.3.2.3. Antibody/antigen sensing
  • 3.4. Gold nanoparticles
  • 3.4.1. AuNPs as energy acceptors for IVD
  • 3.4.1.1. Nucleic acid sensing
  • 3.4.1.2. Protein sensing
  • 3.4.1.3. Small molecule sensing
  • 3.5. Carbon quantum dots
  • 3.5.1. Optical properties of CQDs
  • 3.5.2. CQDs as ET donors for IVD
  • 3.5.2.1. Organic dyes as ET acceptors
  • 3.5.2.2. Metal nanoclusters as ET acceptors
  • 3.5.2.3. QDs as ET acceptors
  • 3.5.2.4. Other nanomaterials as ET acceptors/quenchers
  • 3.6. Perspectives
  • References
  • Chapter 4: Nanoparticles for imaging application
  • 4.1. Introduction
  • 4.2. Imaging modalities
  • 4.3. Nanoparticles for imaging applications
  • 4.3.1. Optical imaging
  • 4.3.2. Ultrasound imaging
  • 4.3.3. Photoacoustic imaging
  • 4.3.4. Computed tomography
  • 4.3.5. Magnetic resonance imaging
  • 4.3.6. Magnetic particle imaging
  • 4.3.7. Positron emission tomography and single photon emission computed tomography
  • 4.3.8. Multimodal imaging
  • 4.4. Perspective
  • References
  • Chapter 5: Colloidal nanoparticles as pharmaceutical agents
  • 5.1. Introduction
  • 5.1.1. Nano-pharmacokinetics (Nano-PK)
  • 5.1.2. Nano-pharmacodynamics (Nano-PD)
  • 5.1.3. Multifunctional efficiency
  • 5.2. Autonomous TNPs
  • 5.2.1. Drug-containing TNPs
  • 5.2.2. Nanoparticles with intrinsic mechanisms for the induction of cell death
  • 5.2.2.1. Reactive oxygen species-generating TNPs
  • 5.2.2.2. Ferroptosis induction
  • 5.2.2.3. Ion overdose
  • 5.2.2.4. Autophagy induction
  • 5.2.2.5. Therapy besides cancer
  • 5.2.2.6. Detoxifying TNPs
  • 5.3. Exogenous energy-converting TNPs
  • 5.3.1. Thermal therapy
  • 5.3.2. Photodynamic therapy
  • 5.3.3. Sonodynamic therapy
  • 5.3.4. Radiotherapy
  • 5.4. Immunotherapeutic nanoparticles

Ejemplares similares